Navigation Links
Drug-Eluting Stents Outperform Bare Stents in Heart Attack
Date:3/30/2008

Anti-clotting drug tirofiban also edges abciximab

CHICAGO, March 30 /PRNewswire/ -- New evidence from a large randomized study is answering important questions about the best approach to percutaneous coronary intervention (PCI) in patients with a type of heart attack known as ST-segment-elevation myocardial infarction (STEMI). In the study, drug-eluting stents outperformed bare-metal stents, and high-dose tirofiban, an anti-clotting medication, proved to be equally effective and have fewer side effects than the catheter lab standard, abciximab.

The study is being reported today in a Late-Breaking Clinical Trials session at the SCAI Annual Scientific Sessions in Partnership with ACC i2 Summit (SCAI-ACCi2) in Chicago. SCAI-ACCi2 is a scientific meeting for practicing cardiovascular interventionalists sponsored by the Society for Cardiovascular Angiography and Interventions (SCAI) in partnership with the American College of Cardiology (ACC). This study is also being simultaneously published online in JAMA: Journal of the American Medical Association.

"These findings may provide a robust scientific rationale for high-dose tirofiban as an alternative to abciximab in patients with STEMI," said Marco Valgimigli, MD, PhD, a cardiologist at the Cardiovascular Institute, Azienda Opedaliera Universitaria di Ferrara, Ferrara, Italy. "In addition, at mid-term follow-up our study did not confirm some of the safety concerns over the use of drug-eluting stents in patients with myocardial infarction. These findings are very reassuring, though we need long-term follow-up to rule out the possibility of late adverse events."

Drug-eluting stents -- which not only prop open the coronary arteries but slowly release medication that prevents re-narrowing of the arteries with scar tissue, or restenosis -- are widely used when PCI is performed for stable coronary artery disease. But many cardiologists use bare-metal stents when treating patients wit
'/>"/>

SOURCE SCAI-ACCi2
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. XTENT Announces Positive Two-Year CUSTOM I and One-Year CUSTOM II Trial Data for Novel Drug-Eluting Stent System
2. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
3. OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) has Lower MACE Rate than TAXUS(R) and CYPHER(R) Stents in Clinical Trial
4. Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures
5. Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety
6. Medifast Outperforms American Diabetes Association Diet by Twice the Weight Loss According to Published Study
7. BRAVE-3 Questions Value of Abciximab in PCI for Heart Attack
8. Stem Cell Research Provides Medical Breakthrough to Repair Heart Cell Damage Created by a Heart Attack
9. DuraHeart(TM) LVAS Receives Conditional Approval for US Pivotal Trial
10. American Heart Association Journal Report: Reducing Kids Salt Intake May Lower Soft Drink Consumption, Reducing Obesity, High Blood Pressure and Later Health Risks
11. Boston Scientific Announces CE Mark Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... , June 30, 2015 Zynerba Pharmaceuticals, Inc. ... Form S-1 with the U.S. Securities and Exchange Commission (SEC) ... stock. The number of shares to be offered and the ... Jefferies LLC and Piper Jaffray & ... and Canaccord Genuity Inc. and Oppenheimer & Co. Inc. will ...
(Date:6/30/2015)... SACRAMENTO, Calif. , June 30, 2015 A ... estimate California,s exposure to high-priced Hepatitis ... even if only 5 percent of Californians infected with Hepatitis ... at the costly impact of new Hepatitis C treatments on ... agencies grapple with hefty price tags for drugs like Gilead ...
(Date:6/30/2015)... TAMPA, Fla. , June 30, 2015  Today, ... four winners of the 2015 National Mobility Awareness Month ... with 914 Local Hero online entries that received 1.3 ... are Chrysler , Toyota Mobility , and ... by BraunAbility and Vantage Mobility International ...
Breaking Medicine Technology:Zynerba Files Registration Statement for Proposed Initial Public Offering of Common Stock 2New Analysis Reveals High-Priced Hepatitis C Drugs Could Have Costly Impact on State 2New Analysis Reveals High-Priced Hepatitis C Drugs Could Have Costly Impact on State 3New Analysis Reveals High-Priced Hepatitis C Drugs Could Have Costly Impact on State 4NMEDA Announces National Contest Winners 2NMEDA Announces National Contest Winners 3
... 4, 2012 Omthera Pharmaceuticals, Inc., a privately-held emerging ... and Chief Executive Officer, will present at the 30th ... 2012 at 8:30am PST at The Westin St. Francis ... Pharmaceuticals, Inc. Founded in 2008, Omthera Pharmaceuticals, Inc. ...
... DES MOINES, Iowa, Jan. 4, 2012  Pharmaceutical marketers who ... spending to maximize ROI have limitless questions. ... optimization methodology developed by RMi with a patent-pending ... hoc reporting to help brand leaders find answers. ...
Cached Medicine Technology:Omthera Pharmaceuticals, Inc. to Present at the 30th Annual J.P. Morgan Healthcare Conference 2RMi Introduces SyntheSight™ Pharma Multi-Channel Optimization Suite 2RMi Introduces SyntheSight™ Pharma Multi-Channel Optimization Suite 3
(Date:6/30/2015)... ... June 30, 2015 , ... The American Lung Association in California ... event in San Diego. Speakers and clean air advocates included San Diego County Supervisor ... of Kindred Hospital, and Daniel Sullivan, founder and president of Sullivan Solar Power. ...
(Date:6/30/2015)... ... June 30, 2015 , ... ... today that they have been awarded the exclusive billing agreements with Jackson Radiology ... of billing services encompassing their proprietary suite of billing process software functionality called ...
(Date:6/30/2015)... ... June 30, 2015 , ... Broadway by the Sea posted its newest ... family member testimonials. Medicare rated the care center as a five-star location based on ... to give future patients a firsthand look at the facility’s satisfied residents. , ...
(Date:6/30/2015)... ... June 30, 2015 , ... Family ... of Colorado's Education Symposium on November 9, 2015 at the Hyatt Regency Denver ... a conversation with Kim and Ashley Campbell, the wife and daughter of singer ...
(Date:6/30/2015)... ... June 30, 2015 , ... Rocky Mountain Oils, a leading non-MLM ... team and added a new CEO, Mr. Darold Francis. The changes will help enhance ... essential oils that customers have come to know and respect for over eight years. ...
Breaking Medicine News(10 mins):Health News:Local Dignitaries Gather to Announce San Diego’s Clean Air Challenge 2Health News:Local Dignitaries Gather to Announce San Diego’s Clean Air Challenge 3Health News:ADVOCATE Wins Billing Agreements with Jackson Radiology Associates 2Health News:Broadway by the Sea Video Promotes Top Quality Service 2Health News:Family of Singer Glen Campbell to Discuss Living with Dementia at the Alzheimer's Association of Colorado's 26th Annual Education Symposium 2Health News:Rocky Mountain Oils Adds New CEO, Announces Relocation of Operations to Orem, Utah 2
... 10, 2010) - The Massachusetts Eye and Ear ... awarded a grant renewal from the National Institutes of ... support first-rate clinician scientists to promote translational and clinical ... NEI renewed a five-year K12 grant to Mass. Eye ...
... 135th Commencement ... ... at the 135th Commencement ceremony for Meharry Medical College on May 22. Commencement ... open at 11:30 a.m., , , , ,Congressman Clyburn is the Majority Whip in the U.S. ...
... nearly tripled in one year, study finds , MONDAY, May ... is gaining popularity in western countries, and those most likely ... their parents, a new study finds. , Young adults in ... to 20-year-old, English-speaking males who live away from their parents ...
... better supportive care helped push the survival for children ... years after diagnosis, according to new research led by ... the medical journal The Lancet Oncology . The ... than previously reported U.S. rates and is similar to ...
... localized cancer, more conservative treatment may be warranted, study finds ... does not seem to extend the life of elderly people ... finds. , Instead, it suggests, people with such cancer should ... their kidneys. , Kidney cancer cases have increased over ...
... ... À la Carte and Packaged Options Including Publishing, Distribution to Major ... and Specialized Radio Media Tour for Sell-Through,“As the publishing industry has ... authors are opting for self-publishing, but they don’t have the marketing ...
Cached Medicine News:Health News:Mass. Eye and Ear receives NEI grant renewal for 'growing' clinical/scientists 2Health News:Congressman James E. Clyburn to Give Meharry Medical College Commencement Address 2Health News:Congressman James E. Clyburn to Give Meharry Medical College Commencement Address 3Health News:Hookahs an Unhealthy Hit Among Privileged Young Adults 2Health News:Hookahs an Unhealthy Hit Among Privileged Young Adults 3Health News:Smarter use of existing treatment helps dramatically boost survival of young AML patients 2Health News:Bookstomarketnow.Com Launches To Provide Publishing, Distribution & Marketing Solutions For The Self-Publishing Author 2Health News:Bookstomarketnow.Com Launches To Provide Publishing, Distribution & Marketing Solutions For The Self-Publishing Author 3Health News:Bookstomarketnow.Com Launches To Provide Publishing, Distribution & Marketing Solutions For The Self-Publishing Author 4Health News:Bookstomarketnow.Com Launches To Provide Publishing, Distribution & Marketing Solutions For The Self-Publishing Author 5Health News:Bookstomarketnow.Com Launches To Provide Publishing, Distribution & Marketing Solutions For The Self-Publishing Author 6
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: